Tetrachlorodecaoxide
Small moleculeexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Nov 2, 1999 (NCT00002119)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
O.O=O.[O-][Cl+][O-].[O-][Cl+][O-].[O-][Cl+][O-].[O-][Cl+][O-]- Mol. weight
- 319.82 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL6067985 ↗
- ChEMBLCHEMBL4299960 ↗
- ChEMBLCHEMBL3707387 ↗
Also known as
- oxoferin
- ryoxon
- tcdo
- tetrachlorodecaoxide
- tetrachlorodecaoxide
- tetrachlorodecaoxide
- tetrachlorodecaoxygen
- wf10
- wf10
- wf10
- wf 10 cpd
- wf10 cpd
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04372355 | Phase 2 | Jun 19, 2019 | Altermed Co.,Ltd., OXO Chemie, Srinakharinwirot University |
| NCT01586468 | Phase 2 | Mar 1, 2010 | Nuvo Research Inc. |
| NCT00002119 | Phase 1 | Nov 2, 1999 | OXO Chemie |
| NCT00002152 | Phase 2 | Nov 2, 1999 | OXO Chemie |
| NCT00002244 | Phase 3 | Nov 2, 1999 | OXO Chemie |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| OXO Chemie | For profit | 4 | 3 | 3 | 1999 |
| Altermed Co.,Ltd. | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Nuvo Research Inc. | For profit | 1 | 1 | 1 | 2010 |
| Srinakharinwirot University | Academic/Hospital | 1 | 1 | 1 | 2019 |
4 organizations
Page 1 / 1